Sarah A. Buchan
- Infectious Diseases top 1%
- SARS-CoV-2 and COVID-19 Research 30
- COVID-19 Clinical Research Studies 11
- Viral gastroenteritis research and epidemiology 8
- Modeling and Simulation top 1%
- COVID-19 epidemiological studies 18
- Health top 1%
- Vaccine Coverage and Hesitancy 20
- Epidemiology top 5%
- Respiratory viral infections research 32
- Influenza Virus Research Studies 22
- Pneumonia and Respiratory Infections 16
- Obstetrics and Gynecology top 5%
- Co-authors
- Jeffrey C. KwongKevin A. BrownNick DanemanSarah E. WilsonKevin L. SchwartzJonathan B. GubbaySharifa NasreenAna Cecilia Ulloa
- Journals
- JAMA (2 papers)Nature Communications (1 paper)SHILAP Revista de lepidopterología (4 papers)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Sarah A. Buchan
84 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 108
- Infectious Diseases 1.3k
- Modeling and Simulation 307
- Health 504
- Epidemiology 655
- Obstetrics and Gynecology 127
Countries citing papers authored by Sarah A. Buchan
This map shows the geographic impact of Sarah A. Buchan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah A. Buchan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah A. Buchan more than expected).
Fields of papers citing papers by Sarah A. Buchan
This network shows the impact of papers produced by Sarah A. Buchan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah A. Buchan. The network helps show where Sarah A. Buchan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sarah A. Buchan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 18 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 0 | |
| 7 | 2023 | 26 | |
| 8 | 2023 | 9 | |
| 9 | 2023 | 4 | |
| 10 | 2023 | 32 | |
| 11 | 2022 | 8 | |
| 12 | Effectiveness of COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe outcomes with variants of concern in Ontariobreakdown → | 2022 | 170 |
| 13 | 2022 | 10 | |
| 14 | 2021 | 17 | |
| 15 | 2021 | 26 | |
| 16 | 2021 | 17 | |
| 17 | 2021 | 5 | |
| 18 | 2021 | 7 | |
| 19 | 2019 | 24 | |
| 20 | 2019 | 3 |
About Sarah A. Buchan
Sarah A. Buchan is a scholar working on Modeling and Simulation, Health and Infectious Diseases, having authored 94 papers that have together received 2.1k indexed citations. Recurring topics across this work include Respiratory viral infections research (32 papers), SARS-CoV-2 and COVID-19 Research (30 papers), Influenza Virus Research Studies (22 papers), Vaccine Coverage and Hesitancy (20 papers), COVID-19 epidemiological studies (18 papers), Pneumonia and Respiratory Infections (16 papers), COVID-19 Clinical Research Studies (11 papers) and Viral gastroenteritis research and epidemiology (8 papers). The work is most often cited by research in Infectious Diseases (1.3k citations), Modeling and Simulation (307 citations) and Health (504 citations). Sarah A. Buchan has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Jeffrey C. Kwong, Kevin A. Brown, Nick Daneman, Sarah E. Wilson, Kevin L. Schwartz, Jonathan B. Gubbay, Sharifa Nasreen, Ana Cecilia Ulloa, Hannah Chung and Mina Tadrous. Their work appears in journals such as JAMA, Nature Communications and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.